Y-box-binding protein 1 (YB1) in breast carcinomas: Relation to aggressive tumor phenotype and identification of patients at high risk for relapse

European Journal of Surgical Oncology

Volumn 40, Issue 3, 2014, Pages 289-296

  Mylona, E ^a   Melissaris, S ^b   Giannopoulou, I ^b   Theohari, I ^b   Papadimitriou, C ^c   Keramopoulos, A ^c   Nakopoulou, L ^b  

^a EVANGELISMOS HOSPITAL   (Greece)

^b UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^c UNIVERSITY OF ATHENS   (Greece)

Author keywords

Breast cancer; Chemotherapy; Immunohistochemistry; Radiotherapy; Recurrence free survival; Y box binding protein

Indexed keywords

BREAST CANCER; CHEMOTHERAPY; IMMUNOHISTOCHEMISTRY; RADIOTHERAPY; RECURRENCE-FREE SURVIVAL; Y-BOX-BINDING PROTEIN;

ADULT; AGED; BIOPSY, NEEDLE; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; COHORT STUDIES; CYTOPLASM; DISEASE-FREE SURVIVAL; DNA-BINDING PROTEINS; FEMALE; FOLLOW-UP STUDIES; GENE EXPRESSION REGULATION, NEOPLASTIC; GREECE; HOSPITALS, UNIVERSITY; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASTIC STEM CELLS; PHENOTYPE; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SURVIVAL ANALYSIS; Y-BOX-BINDING PROTEIN 1;

EID: 84893976269     PISSN: 07487983     EISSN: 15322157     Source Type: Journal    
DOI: 10.1016/j.ejso.2013.09.008     Document Type: Article

References (34)

1. K. Kohno, H. Izumi, T. Uchiumi, M. Ashizuka, and M. Kuwano The pleiotropic functions of the Y-box-binding protein, YB-1 Bioessays 25 2003 691 698
2. I.A. Eliseeva, E.R. Kim, S.G. Guryanov, L.P. Ovichinnikov, and D.N. Lyabin Y-box-binding protein 1 (YB-1) and its functions Biochem (Mosc) 76 2011 1402 1433
3. S. Bergmann, B. Royer-Pokova, and E. Fietze et al. YB-1 provokes breast cancer through the induction of chromosomal instability that emerges from mitotic failure and centrosome amplification Cancer Res 64 2005 4078 4087
4. K. Shibahara, K. Surgio, and T. Osaki et al. Nuclear expression of the Y-box binding protein, YB-1, as a novel marker of disease progression in non-small cell lung cancer Clin Cancer Res 7 2001 3151 3155
5. T. Kamura, H. Yahata, and S. Amada et al. Is nuclear expression of Y-box-binding protein-1 a new prognostic factor in ovarian serous adenocarcinoma? Cancer 85 1999 2450 2454
6. M. Kashihara, K. Azuma, and A. Kawahara et al. Nuclear Y-box binding protein-1, a predictive marker of prognosis, is correlated with expression of HER2/ErbB2 and HER3/ErbB3 in non-small cell lung cancer J Thorac Oncol 4 2009 1066 1074
7. M. Kuwano, Y. Oda, and H. Izumi et al. The role of nuclear Y-box binding protein 1 as a global marker in drug resistance Mol Cancer Ther 3 2004 1485 1492
8. B.W. Sutherland, J. Kucab, and J. Wu et al. Akt phosphorylates the Y-box binding protein 1 at Ser102 located in the cold shock domain and affects the anchorage-independent growth of breast cancer cells Oncogene 24 2005 4281 4292
9. V. Evdokimova, C. Tognon, and T. Ng et al. Translational activation of Snail1 and other developmentally regulated transcription factors by YB-1 promotes an Epithelial-Mesenchymal Transition Cancer Cell 15 2009 402 415
10. S.A. Mani, W. Guo, and M.-J. Liao et al. The epithelial-mesenchymal transition generates cells with properties of stem cells Cell 133 2008 704 715
11. F.A. Tavassoli, and P. Devilee Pathology and genetics: tumors of the breast and female genital organs 2003 WHO Press Lyon IARC WHO Classification of Tumours, No4
12. M.C. Cummings, R. Chambers, P. Simpson, and S.R. Lakhani Molecular classification of breast cancer: is it time to pack up our microscopes? Pathology 43 2011 1 8
13. P. Robins, S. Pinder, and N. de Klerk Histological grading of breast carcinomas: a study of interobserver agreement Hum Pathol 6 1995 873 879
14. TNM classification of international union against cancer P. Hermanek, and H. Sabin TNM atlas, 3rd revision 4th ed. 1992 Springer-Verlag Berlin 15 25
15. L.L. Nakopoulou, A. Alexiadou, G.E. Theodoropoulos, C.A. Lazaris, A. Tzonou, and A. Keramopoulos Prognostic significance of the co-expression of p53 and c-erbB2 proteins in breast cancer J Pathol 179 1996 31 38
16. L. Nakopoulou, A. Michalopoulou, and I. Giannopoulou et al. Bcl-2 protein expression is associated with a prognostically favorable phenotype in breast cancer irrespective of p53 Histopathology 34 1999 310 319
17. + tumor cells in invasive breast carcinomas Hum Pathol 39 2008 1096 1102
18. B. Schittek, K. Psenner, B. Sauer, F. Meier, T. Iftner, and C. Garbe The increased expression of Y box-binding protein 1 in melanoma stimulates proliferation and tumor invasion, antagonizes apoptosis and enhances chemoresistance Int J Cancer 120 2007 2110 2118
19. M.E.H. Hammond, D.F. Hayes, and M. Dowsett et al. American Society of Clinical Oncology/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer J Clin Oncol 28 2010 2786 2795
20. A.C. Wolff, M.E.H. Hammond, and J.N. Schwartz et al. American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer J Clin Oncol 25 2007 118 145
21. E. Dahl, A. En-Nia, and F. Wiesmann et al. Nuclear detection of Y-box protein-1 (YB-1) closely associates with progesterone receptor negativity and is a strong adverse survival factor in human breast cancer BMC Cancer 9 2009 410 417
22. T. Fujii, A. Kawahara, and Y. Basaki et al. Expression of HER2 and estrogen receptor a depends upon nuclear localization of Y-box binding protein 1 in human breast cancers Cancer Res 68 2008 1504 1512
23. M. Janz, N. Harbeck, and P. Dettmar et al. Y-box factor YB-1 predicts drug resistance and patient outcome in breast cancer independent of clinically relevant tumor biologic factors HER2, uPA and PAI-1 Int J Cancer 97 2002 278 282
24. J. Huang, P.-H. Tan, K.-B. Li, K. Matsumoto, M. Tsujimoto, and B.-H. Bay Y-box binding protein, YB-1, as a marker of tumor aggressiveness and response to adjuvant chemotherapy in breast cancer Int J Oncol 26 2005 607 613
25. O. Gluz, K. Mengele, and M. Schmitt et al. Y-box-binding protein YB-1 identifies high-risk patients with primary breast cancer benefiting from rapidly cycled tandem high-dose adjuvant chemotherapy J Clin Oncol 27 2009 6144 6151
26. G. Habibi, S. Leung, and J.H. Law et al. Redefining prognostic factors for breast cancer: YB-1 is a stronger predictor of relapse and disease-specific survival than estrogen receptor of HER2 across all tumor subtypes Breast Cancer Res 10 2008 R86
27. J. Wu, C. Lee, and D. Yokom et al. Disruption of the Y-box binding protein-1 results in suppression of the epidermal growth factor receptor and HER-2 Cancer Res 66 2006 4872 4878
28. Y.-N. Yu, G.W.-C. Yip, and P.-M. Tan et al. Y-box binding protein 1 is up-regulated in proliferative breast cancer and its inhibition deregulates the cell cycle Int J Oncol 37 2010 483 492
29. M. Ladomery, and J. Sommerville A role for Y-box proteins in cell proliferation Bioessays 17 1995 9 11
30. M.M. Gottesman, and I. Pastan Biochemistry of multidrug resistance mediated by the multidrug transporter Annu Rev Biochem 62 1993 385 427
31. R.C. Bargou, K. Jürchott, and C. Wagener et al. Nuclear localization and increased levels of transcription factor YB-1 in primary human breast cancers are associated with intrinsic MDR1 gene expression Nat Med 3 1997 447 450
32. W.-L. Tay, G.W.-C. Yip, and P.-H. Tan et al. Y-box-binding protein 1 is a promising predictive marker of radioresistance and chemoresistance in nasopharyngeal cancer Mod Pathol 22 2009 282 290
33. K. Koike, T. Uchiumi, and T. Ohga et al. Nuclear translocation of the Y-box binding protein by ultraviolet irradiation FEBS Lett 417 1997 390 394
34. K. To, A. Fotovati, and K.M. Reipas et al. Y-box binding protein-1 induces the expression of CD44 and CD49f leading to enhanced self-renewal, mammosphere growth, and drug resistance Cancer Res 70 2010 2840 2851